Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among north Indian individuals

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 453-456

  Rathore, Anurag ^a   Chatterjee, Animesh ^a   Yamamoto, Naohiko ^b   Dhole, Tapan N ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS REPLICATION;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CYTIDINE DEAMINASE; EXONS; FEMALE; GENOTYPE; GEOGRAPHY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 50649118326     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2008.0017     Document Type: Article

References (21)

1. An P, Bleiber G, Duggal P, et al. (2004) APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 78(20):11070-11076.
2. Cao Y, Qin L, Zhang L, et al. (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332(4):201-208.
3. Chiu YL, Soros VB, Kreisberg JF, et al. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+T cells. Nature 435(7038):108-114.
4. Cho SJ, Drechsler H, Burke RC, et al. (2006) APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+T-cell count. J Virol 80(4):2069-2072.
5. Do H, Vasilescu A, Diop G, et al. (2005) Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. J Infect Dis 191(2):159-163.
6. Fowke KR, Nagelkerke NJ, Kimani J, et al. (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348(9038):1347-1351.
7. Lehner T (2003) Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine 21 Suppl 2:S68-S76. Review.
8. Levy JA, Scott I, Mackewicz C (2003) Protection from HIV/AIDS: the importance of innate immunity. Clin Immunol 108(3):167-174. Review.
9. Liu H, Carrington M, Wang C, et al. (2006) Repeat-region polymorphisms in the gene for dendritic cell- specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule. Effects on HIV susceptibility. J Infect Dis 193:698-702.
10. Liu H, Hwangbo Y, Holtc S, et al. (2004) Analysis of genetic polymorphisms in CCR5. CCR2 stromal cell -derived factor-1, RANTES and dendritic cell- specific intercellular adhesion molecular-3-grabbing nonintegrin in seronegative individual repeatedly exposed to HIV-1. J Infect Dis 190:1055-1058.
11. Mangeat B, Turelli P, Caron G, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424(6944):99-103.
12. Mariani R, Chen D, Schröfelbauer B, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114(1):21-31.
13. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9(11):1398-1403.
14. Peng G, Lei KJ, Jin W, et al. (2006) Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203(1):41-46.
15. Rathore A, Chatterjee A, Sivarama P, et al. (2008a) Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals. J Clin Immunol 28(1):50-57.
16. Rathore A, Chatterjee A, Sood V, et al. (2008b) Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians. Clin Chim Acta 391(1-2):1-5.
17. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418(6898):646-650.
18. Valcke HS, Bernard NF, Bruneau J, et al. (2006) APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. AIDS 20(15):1984-1986.
19. Yu X, Yu Y, Liu B, et al. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302(5647):1056-1060.
20. Zhang H, Yang B, Pomerantz RJ, et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424(6944):94-98.
21. Zheng YH, Irwin D, Kurosu T, et al. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78(11):6073-6076.